Cboe Files to List Canary Capital’s Staked Injective ETF, Potentially Following Solana and Ether Models
Main Idea
The Cboe has filed to list Canary Capital’s staked Injective ETF, which would become the third staked crypto ETF in the US, offering investors regulated exposure to Injective’s governance token and staking rewards.
Key Points
1. The Chicago Board Options Exchange (Cboe) submitted a Form 19b-4 filing to list Canary Capital’s staked Injective ETF, following approved staked Solana and Ether ETFs.
2. If approved, the ETF could boost liquidity and market visibility for INJ, which has seen a price decline from its all-time high of $52 to around $15.10.
3. The regulatory environment for crypto ETFs in the US has become more favorable, with the SEC acknowledging staking as a fundamental component of blockchain networks.
4. The SEC’s review process for the staked Injective ETF can take up to 240 days, with a final decision expected by March 2026.
5. Market reactions to crypto ETFs vary; Bitcoin’s price surged post-ETF approval, while Ethereum’s spot ETF saw a price drop of over 38% within two weeks.
Description
Are You Chasing New Coins? Catch the newest crypto opportunities. Be the first to buy, be the first to win! Click here to discover new altcoins! The Cboe has
Latest News
- SEC May Extend Review of BlackRock’s Spot Ethereum ETF Staking Proposal Amid Industry Interest2025-07-29 21:17:08
- SEC Approves In-Kind Redemptions for Bitcoin ETFs, Potentially Enhancing Market Efficiency2025-07-29 20:56:49
- Bitcoin Eyes Potential Breakout to $122,000 Amid Fading ETF Flows and Seasonal Risks2025-07-29 20:55:34
- SEC May Allow In-Kind Redemptions for Bitcoin ETFs, Potentially Enhancing Market Efficiency2025-07-29 20:54:56
- Ethereum Exit Queue Nears $2.64 Billion Amid Institutional Activity and Market Dynamics2025-07-29 20:42:33